Klocker H - Search Results

1

Dual role of allele-specific DNA hypermethylation within the TERT promoter in cancer.

Lee DD, Komosa M, Sudhaman S, Leão R, Zhang CH, Apolonio JD, Hermanns T, Wild PJ, Klocker H, Nassiri F, Zadeh G, Diplas BH, Yan H, Gallinger S, Pugh TJ, Ramaswamy V, Taylor MD, Castelo-Branco P, Nunes NM, Tabori U. Lee DD, et al. Among authors: klocker h. J Clin Invest. 2021 Nov 1;131(21):e146915. doi: 10.1172/JCI146915. J Clin Invest. 2021. PMID: 34720085 Free PMC article.

2

A cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: a retrospective cohort study.

Castelo-Branco P, Leão R, Lipman T, Campbell B, Lee D, Price A, Zhang C, Heidari A, Stephens D, Boerno S, Coelho H, Gomes A, Domingos C, Apolonio JD, Schäfer G, Bristow RG, Schweiger MR, Hamilton R, Zlotta A, Figueiredo A, Klocker H, Sültmann H, Tabori U. Castelo-Branco P, et al. Among authors: klocker h. Oncotarget. 2016 Sep 6;7(36):57726-57736. doi: 10.18632/oncotarget.10639. Oncotarget. 2016. PMID: 27437772 Free PMC article.

3

Androgen signal transduction and prostatic carcinoma.

Klocker H, Culig Z, Kaspar F, Hobisch A, Eberle J, Reissigl A, Bartsch G. Klocker H, et al. World J Urol. 1994;12(2):99-103. doi: 10.1007/BF00184245. World J Urol. 1994. PMID: 8087144 Review.

4

Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.

Culig Z, Stober J, Gast A, Peterziel H, Hobisch A, Radmayr C, Hittmair A, Bartsch G, Cato AC, Klocker H. Culig Z, et al. Among authors: klocker h. Cancer Detect Prev. 1996;20(1):68-75. Cancer Detect Prev. 1996. PMID: 8907206

5

Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor.

Hobisch A, Eder IE, Putz T, Horninger W, Bartsch G, Klocker H, Culig Z. Hobisch A, et al. Among authors: klocker h. Cancer Res. 1998 Oct 15;58(20):4640-5. Cancer Res. 1998. PMID: 9788616

6

Genes differentially expressed in prostate cancer.

Eder IE, Bektic J, Haag P, Bartsch G, Klocker H. Eder IE, et al. Among authors: klocker h. BJU Int. 2004 May;93(8):1151-5. doi: 10.1111/j.1464-410X.2004.04869.x. BJU Int. 2004. PMID: 15142130 Review.

7

Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients.

Fiegl H, Millinger S, Mueller-Holzner E, Marth C, Ensinger C, Berger A, Klocker H, Goebel G, Widschwendter M. Fiegl H, et al. Among authors: klocker h. Cancer Res. 2005 Feb 15;65(4):1141-5. doi: 10.1158/0008-5472.CAN-04-2438. Cancer Res. 2005. PMID: 15734995

8

The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection.

Bu H, Bormann S, Schäfer G, Horninger W, Massoner P, Neeb A, Lakshmanan VK, Maddalo D, Nestl A, Sültmann H, Cato AC, Klocker H. Bu H, et al. Among authors: klocker h. Prostate. 2011 May;71(6):575-87. doi: 10.1002/pros.21273. Epub 2010 Oct 13. Prostate. 2011. PMID: 20945500

9

Lovastatin causes diminished PSA secretion by inhibiting AR expression and function in LNCaP prostate cancer cells.

Yang L, Egger M, Plattner R, Klocker H, Eder IE. Yang L, et al. Among authors: klocker h. Urology. 2011 Jun;77(6):1508.e1-7. doi: 10.1016/j.urology.2010.12.074. Urology. 2011. PMID: 21624609

10

PIAS1 is increased in human prostate cancer and enhances proliferation through inhibition of p21.

Hoefer J, Schäfer G, Klocker H, Erb HH, Mills IG, Hengst L, Puhr M, Culig Z. Hoefer J, et al. Among authors: klocker h. Am J Pathol. 2012 May;180(5):2097-107. doi: 10.1016/j.ajpath.2012.01.026. Epub 2012 Mar 23. Am J Pathol. 2012. PMID: 22449952 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

329 results

Search Page